Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lacer prepares new strontium salts for osteoporosis

Jan. 2, 2013

Kissei submits application in Japan for combination therapy including Glufast

Dec. 31, 2012

New conjugate presented for metabolic syndrome

Dec. 31, 2012

Japanese MHLW approves Novo Nordisk's combination therapy for diabetes

Dec. 28, 2012

Otsuka obtains new approvals for carnitine deficiency treatments

Dec. 28, 2012

Japanese researchers patent new insulin secretagogues

Dec. 28, 2012

Takeda and Amylin terminate worldwide agreement

Dec. 28, 2012

Once-monthly formulation of antiosteoporotic agent approved in Japan

Dec. 27, 2012

FDA approves Juxtapid for homozygous familial hypercholesterolemia

Dec. 27, 2012

Raptor Pharmaceutical provides update on NDA review for Procysbi

Dec. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...